LDRH SEC-arkiveringar - iShares Trust - iShares iBonds 1-5 Year High Yield and Income Ladder ETF- Årsredovisning, Fullmaktsutlåtande, prospekt

Grundläggande statistik

CIK

1348324

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to iShares Trust - iShares iBonds 1-5 Year High Yield and Income Ladder ETF

SEC Filings (Chronological Order)

Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.

July 25, 2016	15-12B	LDR Holding FORM 15 Form 15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-36095 LDR HOLDING CORPORATION (Exact name of registrant as spec
July 18, 2016	EX-3.2	LDR HOLDING CORPORATION AMENDED AND RESTATED BY-LAWS ARTICLE I Meetings of Stockholders EX-3.2 Exhibit 3.2 LDR HOLDING CORPORATION AMENDED AND RESTATED BY-LAWS ARTICLE I Meetings of Stockholders Section 1.1 Annual Meetings. The annual meeting of the stockholders for the election of directors and for the transaction of such other business as properly may come before such meeting shall be held each year on such date, and at such time and place within or without the State of Delaware, a
July 18, 2016	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2016 (July 13, 2016) LDR HOLDING CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 001-36095 20-3933262 (State or other jurisdiction of inc
July 18, 2016	EX-3.1	AMENDED AND RESTATED CERTIFICATE OF INCORPORATION LDR HOLDING CORPORATION EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF LDR HOLDING CORPORATION FIRST: The name of the corporation (the ?Corporation?) is LDR Holding Corporation SECOND: The registered office of the Corporation in the State of Delaware is located at Corporation Service Company, 2711 Centerville Road, Suite 400, Wilmington, County of Newcastle, Delaware 19808. The name of its regist
July 15, 2016	SC 13D/A	LDRH / LDR Holding Corp / Magnetar Financial LLC - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* LDR HOLDING CORPORATION (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 50185U105 (CUSIP Number of Class of Securities) Alec N. Litowitz Magnetar Capital LLC 1603 Orrington Ave. Evanston, Illinois 60201
July 13, 2016	POS AM	LDR Holding POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on July 13, 2016 Registration No. 333-199882 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 LDR HOLDING CORPORATION (Exact name of registrant as specified in its charter) Delaware
July 13, 2016	S-8 POS	LDR Holding POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 S-8 POS 1 d214778ds8pos.htm POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 As filed with the Securities and Exchange Commission on July 13, 2016 Registration No. 333-209650 Registration No. 333-202210 Registration No. 333-194336 Registration No. 333-191663 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE
July 13, 2016	S-8 POS	LDR Holding POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 13, 2016 Registration No. 333-209650 Registration No. 333-202210 Registration No. 333-194336 Registration No. 333-191663 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 LDR
July 13, 2016	S-8 POS	LDR Holding POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 13, 2016 Registration No. 333-209650 Registration No. 333-202210 Registration No. 333-194336 Registration No. 333-191663 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 LDR
July 13, 2016	S-8 POS	LDR Holding POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 13, 2016 Registration No. 333-209650 Registration No. 333-202210 Registration No. 333-194336 Registration No. 333-191663 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 LDR
July 13, 2016	SC 14D9/A	LDR Holding SC 14D-9 (AMENDMENT NO. 2) SC 14D-9 (Amendment No. 2) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2) LDR HOLDING CORPORATION (Name of Subject Company) LDR HOLDING CORPORATION (Name of Persons Filing Statement) Common Stock, par value $0.001 per share (Ti
July 13, 2016	SC TO-T/A	LDR Holding SC TO-T (AMENDMENT NO. 2) SC TO-T (Amendment No. 2) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Amendment No. 2 Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 LDR HOLDING CORPORATION (Name of Subject Company) LH MERGER SUB, INC. (Offeror) an indirect wholly owned subsidiary of ZIMMER BIOMET HOLDINGS, INC. (Parent of Offeror) (Na
July 13, 2016	EX-99.(A)(5)(N)	Zimmer Biomet Completes Tender Offer for Outstanding Shares of LDR Holding Corporation Strategic Combination Expands Portfolio of Innovative Solutions for $10 Billion Spine Market EX-99.(a)(5)(N) Exhibit (a)(5)(N) 345 E. Main St. Warsaw, IN 46580 Contacts: Media Investors Monica Kendrick Robert J. Marshall Jr. 574-372-4989 574-371-8042 [email protected] [email protected] Barbara Goslee 574-371-9449 [email protected] Zimmer Biomet Completes Tender Offer for Outstanding Shares of LDR Holding Corporation Strategic Combination Expands Po
June 27, 2016	SC 14D9/A	LDR Holding SC 14D-9 (AMENDMENT NO. 1) SC 14D-9 (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 (Amendment No. 1) LDR HOLDING CORPORATION (Name of Subject Company) LDR HOLDING CORPORATION (Name of Persons Filing Statement) Common Stock, par value $0.001 per share (Ti
June 27, 2016	SC TO-T/A	LDR Holding SC TO-T/A SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Amendment No. 1 Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 LDR HOLDING CORPORATION (Name of Subject Company) LH MERGER SUB, INC. (Offeror) an indirect wholly owned subsidiary of ZIMMER BIOMET HOLDINGS, INC. (Parent of Offeror) (Names of Filing Pe
June 27, 2016	EX-99.(A)(5)(M)	Zimmer Biomet Announces Early Termination of HSR Waiting Period EX-99.(a)(5)(M) Exhibit (a)(5)(M) 345 E. Main St. Warsaw, IN 46580 Contacts: Media Investors Monica Kendrick Robert J. Marshall Jr. 574-372-4989 574-371-8042 [email protected] [email protected] Barbara Goslee 574-371-9449 [email protected] Zimmer Biomet Announces Early Termination of HSR Waiting Period (WARSAW, IN) June 27, 2016 ? Zimmer Biomet Holdings, In
June 20, 2016	EX-99.1	JOINT FILING AGREEMENT EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k), as promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of LDR Holding Corporation and further agree that this Joint Filing Agreement be incl
June 20, 2016	SC 13D	LDRH / LDR Holding Corp / Magnetar Financial LLC - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* LDR HOLDING CORPORATION (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 50185U105 (CUSIP Number of Class of Securities) Alec N. Litowitz Magnetar Capital LLC 1603 Orrington Ave. Evanston, Illinois 60201 (84
June 14, 2016	SC 14D9	LDR Holding SC 14D-9 SC 14D-9 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
June 14, 2016	EX-99.(A)(1)(A)	Offer to Purchase for Cash All Outstanding Shares of Common Stock LDR HOLDING CORPORATION $37.00 Per Share, Net in Cash, LH MERGER SUB, INC. an indirect wholly owned subsidiary of ZIMMER BIOMET HOLDINGS, INC. EX-99.(a)(1)(A) Table of Contents Exhibit (a)(1)(A) Offer to Purchase for Cash All Outstanding Shares of Common Stock of LDR HOLDING CORPORATION at $37.00 Per Share, Net in Cash, by LH MERGER SUB, INC. an indirect wholly owned subsidiary of ZIMMER BIOMET HOLDINGS, INC. THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, NEW YORK CITY TIME, ON JULY 13, 2016 (ONE MINUTE AFTER 11:59 P.M.,
June 14, 2016	EX-99.(A)(1)(E)	Letter to Clients with Respect to the Offer to Purchase All Outstanding Shares of Common Stock LDR HOLDING CORPORATION $37.00 Per Share, Net in Cash, Pursuant to the Offer to Purchase dated June 14, 2016 LH MERGER SUB, INC., an indirect wholly owned EX-99.(a)(1)(E) Exhibit (a)(1)(E) Letter to Clients with Respect to the Offer to Purchase All Outstanding Shares of Common Stock of LDR HOLDING CORPORATION at $37.00 Per Share, Net in Cash, Pursuant to the Offer to Purchase dated June 14, 2016 by LH MERGER SUB, INC., an indirect wholly owned subsidiary of ZIMMER BIOMET HOLDINGS, INC. THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, N
June 14, 2016	EX-99.(A)(1)(D)	Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees with Respect to the Offer to Purchase All Outstanding Shares of Common Stock LDR HOLDING CORPORATION $37.00 Per Share, Net in Cash, Pursuant to the Offer to Purchase dat EX-99.(a)(1)(D) Exhibit (a)(1)(D) Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees with Respect to the Offer to Purchase All Outstanding Shares of Common Stock of LDR HOLDING CORPORATION at $37.00 Per Share, Net in Cash, Pursuant to the Offer to Purchase dated June 14, 2016 by LH MERGER SUB, INC., an indirect wholly owned subsidiary of ZIMMER BIOMET HOLDINGS, INC. T
June 14, 2016	EX-99.(D)(2)	LDR HOLDING CORPORATION 13785 Research Blvd., Suite 200 Austin, TX 78750 March 21, 2016 EX-99.(d)(2) Exhibit (d)(2) LDR HOLDING CORPORATION 13785 Research Blvd., Suite 200 Austin, TX 78750 March 21, 2016 CONFIDENTIAL Zimmer Biomet Holdings, Inc. 345 East Main Street Warsaw, IN 46580 Attention: Chad F. Phipps, General Counsel Ladies and Gentlemen: In connection with the consideration by LDR Holding Corporation (the “Company”) and Zimmer Biomet Holdings, Inc. (“Interested Party”) of a
June 14, 2016	EX-99.(D)(5)	[SIGNATURE PAGE FOLLOWS] EX-99.(d)(5) Exhibit (d)(5) June 6, 2016 Christophe Lavigne 13785 Research Boulevard, Suite 200 Austin, TX 78750 Re: EMPLOYMENT TERMS Dear Christophe: Zimmer Biomet Holdings, Inc., a corporation organized under the laws of Delaware (the “Company”) is pleased to offer you employment as Vice President of Spine Strategy, on the terms and conditions set forth in this letter agreement (this “Agreement”
June 14, 2016	EX-99.(D)(6)	Zimmer Biomet Holdings, Inc. 56 East Bell Drive Warsaw, Indiana 46580 Exhibit (d)(6) Zimmer Biomet Holdings, Inc. 56 East Bell Drive Warsaw, Indiana 46580 June 6, 2016 Mr. Patrick Richard [Address] Re: Employment and Consulting Engagement Mr. Richard: Reference is made to the Agreement and Plan of Merger (the “Merger Agreement”), dated June 6, 2016, by and among Zimmer Biomet Holdings, Inc., a Delaware corporation (“Zimmer”), LDR Holding Corporation, a Delaware corp
June 14, 2016	EX-99.(A)(1)(C)	Notice of Guaranteed Delivery Offer to Purchase All Outstanding Shares of Common Stock LDR HOLDING CORPORATION $37.00 Per Share, Net in Cash, Pursuant to the Offer to Purchase dated June 14, 2016 LH MERGER SUB, INC., an indirect wholly owned subsidia EX-99.(a)(1)(C) Exhibit (a)(1)(C) Notice of Guaranteed Delivery for Offer to Purchase All Outstanding Shares of Common Stock of LDR HOLDING CORPORATION at $37.00 Per Share, Net in Cash, Pursuant to the Offer to Purchase dated June 14, 2016 by LH MERGER SUB, INC., an indirect wholly owned subsidiary of ZIMMER BIOMET HOLDINGS, INC. THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, NEW Y
June 14, 2016	SC TO-T	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 LDR HOLDING CORPORATION (Name of Subject Company) LH MERGER SUB, INC. SC TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 LDR HOLDING CORPORATION (Name of Subject Company) LH MERGER SUB, INC. (Offeror) an indirect wholly owned subsidiary of ZIMMER BIOMET HOLDINGS, INC. (Parent of Offeror) (Names of Filing Persons) Common stock, par
June 14, 2016	EX-99.(A)(1)(F)	Notice of Offer to Purchase All Outstanding Shares of Common Stock LDR Holding Corporation $37.00 Per Share, Net in Cash, Pursuant to the Offer to Purchase dated June 14, 2016 LH Merger Sub, Inc., an indirect wholly owned subsidiary of Zimmer Biomet EX-99.(a)(1)(F) Exhibit (a)(1)(F) This announcement is neither an offer to purchase nor a solicitation of an offer to sell Shares (as defined below). The Offer (as defined below) is made only by the Offer to Purchase, dated June 14, 2016, and the related Letter of Transmittal (as defined below) and any amendments or supplements thereto, and is being made to all holders of Shares. The Offer is not
June 14, 2016	EX-99.(D)(3)	Certain Material Terms of the Proposed Definitive Transaction Agreement EX-99.(d)(3) Exhibit (d)(3) May 4, 2016 STRICTLY CONFIDENTIAL LDR Holding Corporation 13785 Research Boulevard Suite 200 Austin, TX 78750 Subject: Exclusivity Agreement Ladies and Gentlemen: 1. We have been advised of LDR Holding Corporation’s (“LDR”) desire to continue discussions with Zimmer Biomet Holdings, Inc. (“Zimmer Biomet”) with respect to a possible acquisition of LDR by Zimmer Biomet (t
June 14, 2016	EX-99.(D)(4)	[signature page follows] EX-99.(d)(4) Exhibit (d)(4) June 3, 2016 STRICTLY CONFIDENTIAL LDR Holding Corporation 13785 Research Boulevard Suite 200 Austin, TX 78750 Subject: Extension of Exclusivity Period Ladies and Gentlemen: Reference is made to that certain letter agreement (the “Agreement”), dated as of May 4, 2016, by and between LDR Holding Corporation (“LDR”) and Zimmer Biomet Holdings, Inc. (“Zimmer Biomet”). Subs
June 14, 2016	EX-99.(A)(1)(B)	LETTER OF TRANSMITTAL To Tender Shares of Common Stock LDR HOLDING CORPORATION $37.00 Per Share, Net in Cash, Pursuant to the Offer to Purchase dated June 14, 2016 LH MERGER SUB, INC., an indirect wholly owned subsidiary of ZIMMER BIOMET HOLDINGS, IN EX-99.(a)(1)(B) Exhibit (a)(1)(B) LETTER OF TRANSMITTAL To Tender Shares of Common Stock of LDR HOLDING CORPORATION at $37.00 Per Share, Net in Cash, Pursuant to the Offer to Purchase dated June 14, 2016 by LH MERGER SUB, INC., an indirect wholly owned subsidiary of ZIMMER BIOMET HOLDINGS, INC. THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, NEW YORK CITY TIME, ON JULY 13, 2016 (ONE
June 10, 2016	SC TO-C	LDR Holding SC TO-C SC TO-C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 LDR HOLDING CORPORATION (Name of Subject Company) LH MERGER SUB, INC. (Offeror) ZIMMER BIOMET HOLDINGS, INC. (Parent of Offeror) (Names of Filing Persons) Common stock, par value $0.001 per share (Title of
June 7, 2016	SC14D9C	LDR Holding SC14D9C SC14D9C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 LDR HOLDING CORPORATION (Name of Subject Company) LDR HOLDING CORPORATION (Name of Persons Filing Statement) Common Stock, par value $0.001 per share (Title of Class of Securities) 50185U105
June 7, 2016	SC TO-C	LDR Holding SC TO-C SC TO-C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 LDR HOLDING CORPORATION (Name of Subject Company) LH MERGER SUB, INC. (Offeror) ZIMMER BIOMET HOLDINGS, INC. (Parent of Offeror) (Names of Filing Persons) Common stock, par value $0.001 per share (Title of
June 7, 2016	EX-2.1	AGREEMENT AND PLAN OF MERGER BY AND AMONG ZIMMER BIOMET HOLDINGS, INC., LH MERGER SUB, INC., LDR HOLDING CORPORATION Dated as of June 6, 2016 TABLE OF CONTENTS Page ARTICLE I CERTAIN DEFINITIONS 2 1.1 Definitions 2 1.2 Additional Definitions 11 1.3 R EX-2.1 Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER BY AND AMONG ZIMMER BIOMET HOLDINGS, INC., LH MERGER SUB, INC., AND LDR HOLDING CORPORATION Dated as of June 6, 2016 TABLE OF CONTENTS Page ARTICLE I CERTAIN DEFINITIONS 2 1.1 Definitions 2 1.2 Additional Definitions 11 1.3 Rules of Construction 13 ARTICLE II THE OFFER 14 2.1 The Offer 14 2.2 Actions of Parent and Merger Sub 16 2.3
June 7, 2016	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2016 LDR HOLDING CORPORATION (Exact name of registrant as specified in its charter) DELAWARE (State or other jurisdiction of incorporation) 001-36095 (Commission File Number)
June 7, 2016	EX-2.1	AGREEMENT AND PLAN OF MERGER BY AND AMONG ZIMMER BIOMET HOLDINGS, INC., LH MERGER SUB, INC., LDR HOLDING CORPORATION Dated as of June 6, 2016 TABLE OF CONTENTS Page ARTICLE I CERTAIN DEFINITIONS 2 1.1 Definitions 2 1.2 Additional Definitions 11 1.3 R EX-2.1 2 d206896dex21.htm EX-2.1 Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER BY AND AMONG ZIMMER BIOMET HOLDINGS, INC., LH MERGER SUB, INC., AND LDR HOLDING CORPORATION Dated as of June 6, 2016 TABLE OF CONTENTS Page ARTICLE I CERTAIN DEFINITIONS 2 1.1 Definitions 2 1.2 Additional Definitions 11 1.3 Rules of Construction 13 ARTICLE II THE OFFER 14 2.1 The Offer 14 2.2 Actions of Par
June 7, 2016	SC TO-C	LDR Holding 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2016 ZIMMER BIOMET HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-16407 13-4151777 (State or other jurisdiction of incorporation) (Comm
June 7, 2016	EX-99.2	1 EX-99.2 Exhibit 99.2 LDR Employee FAQ 1. What was announced today? ? We announced that our Board of Directors has approved a Merger Agreement with Zimmer Biomet under which Zimmer Biomet will commence a tender offer to acquire all of the outstanding shares of LDR for $37.00 per share in cash, which implies a transaction value of approximately $1.1 billion. This transaction will combine the innovat
June 7, 2016	EX-99.1	1 EX-99.1 Exhibit 99.1 To all LDR employees, I am excited to announce that the LDR Board of Directors has accepted an offer from Zimmer Biomet to acquire LDR. Zimmer Biomet is a global leader in musculoskeletal healthcare committed to helping people live better lives. Zimmer Biomet will acquire all of the outstanding shares of LDR common stock for $37.00 per share in cash, which implies a transactio
June 7, 2016	EX-99.6	Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking information related to Zimmer Biomet, LDR and the acquisition of LDR by Zimmer Biomet that involves substantial risks and uncertainties that could c EX-99.6 Zimmer Biomet Announces Agreement to Acquire LDR David Dvorak President and CEO Christophe Lavigne LDR Co-Founder, Chairman, President and CEO Dan Florin SVP and CFO Adam Johnson Group President, Spine, CMF and Thoracic, and Dental June 7, 2016 Exhibit 99.6 Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking information related to Zimmer Bi
June 7, 2016	EX-99.5	ZIMMER BIOMET TO ACQUIRE LDR TO ENHANCE INNOVATION AND GROWTH OF SPINE BUSINESS EX-99.5 6 d208800dex995.htm EX-99.5 Exhibit 99.5 345 E. Main St. Warsaw, IN 46580 www.zimmerbiomet.com Contacts: Media Investors Monica Kendrick Robert J. Marshall Jr. 574-372-4989 574-371-8042 [email protected] [email protected] Barbara Goslee 574-371-9449 [email protected] ZIMMER BIOMET TO ACQUIRE LDR TO ENHANCE INNOVATION AND GROWTH OF SPINE BUSINESS • S
June 7, 2016	EX-99.3	1 EX-99.3 Exhibit 99.3 June 7, 2016 Dear Valued LDR Customer, Today is an exciting day for LDR. This morning, it was announced that Zimmer Biomet will be acquiring LDR and merging it with its existing spine business. The transaction is expected to close in the third quarter of 2016, subject to the satisfaction of customary closing conditions. Until then, LDR and Zimmer Biomet will remain independent
June 7, 2016	EX-99.4	1 EX-99.4 Exhibit 99.4 June 7, 2016 Dear Valued LDR Product Designer or Consultant, Today is an exciting day for LDR. This morning, it was announced that Zimmer Biomet will be acquiring LDR and merging it with its existing spine business. The transaction is expected to close in the third quarter of 2016, subject to the satisfaction of customary closing conditions. Until then, LDR and Zimmer Biomet w
June 7, 2016	SC14D9C	LDR Holding SC14D9C SC14D9C 1 d208800dsc14d9c.htm SC14D9C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 LDR HOLDING CORPORATION (Name of Subject Company) LDR HOLDING CORPORATION (Name of Persons Filing Statement) Common Stock, par value $0.001 per share (Title of
June 7, 2016	SC TO-C	LDR Holding SC TO-C SC TO-C 1 d208965dsctoc.htm SC TO-C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 LDR HOLDING CORPORATION (Name of Subject Company) LH MERGER SUB, INC. (Offeror) ZIMMER BIOMET HOLDINGS, INC. (Parent of Offeror) (Names of Filing Persons) Common stock, par valu
June 7, 2016	EX-99.1	ZIMMER BIOMET TO ACQUIRE LDR TO ENHANCE INNOVATION AND GROWTH OF SPINE BUSINESS EX-99.1 2 d206650dex991.htm EX-99.1 Exhibit 99.1 345 E. Main St. Warsaw, IN 46580 www.zimmerbiomet.com Contacts: Media Investors Monica Kendrick Robert J. Marshall Jr. 574-372-4989 574-371-8042 [email protected] [email protected] Barbara Goslee 574-371-9449 [email protected] ZIMMER BIOMET TO ACQUIRE LDR TO ENHANCE INNOVATION AND GROWTH OF SPINE BUSINESS • S
June 7, 2016	8-K	Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 6, 2016 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-36095 20-3933262 (State or Other Jurisdiction of Incorporation) (Commissio
June 7, 2016	SC TO-C	LDR Holding 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2016 ZIMMER BIOMET HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-16407 13-4151777 (State or other jurisdiction of incorporation) (Comm
June 7, 2016	EX-99.2	Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking information related to Zimmer Biomet, LDR and the acquisition of LDR by Zimmer Biomet that involves substantial risks and uncertainties that could c EX-99.2 3 d208796dex992.htm EX-99.2 Zimmer Biomet Announces Agreement to Acquire LDR David Dvorak President and CEO Christophe Lavigne LDR Co-Founder, Chairman, President and CEO Dan Florin SVP and CFO Adam Johnson Group President, Spine, CMF and Thoracic, and Dental June 7, 2016 Exhibit 99.2 Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking info
June 7, 2016	EX-99.1	ZIMMER BIOMET TO ACQUIRE LDR TO ENHANCE INNOVATION AND GROWTH OF SPINE BUSINESS EX-99.1 2 d208796dex991.htm EX-99.1 Exhibit 99.1 345 E. Main St. Warsaw, IN 46580 www.zimmerbiomet.com Contacts: Media Investors Monica Kendrick Robert J. Marshall Jr. 574-372-4989 574-371-8042 [email protected] [email protected] Barbara Goslee 574-371-9449 [email protected] ZIMMER BIOMET TO ACQUIRE LDR TO ENHANCE INNOVATION AND GROWTH OF SPINE BUSINESS • S
May 13, 2016	8-K	Entry into a Material Definitive Agreement SEC Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 9, 2016 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission F
May 10, 2016	EX-10.2	Range Commercial reference Commercial designation [*] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] [] SEC Exhibit EXHIBIT 10.2 [*] indicates material has been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. A complete copy of this agreement, including redacted portions so indicated, has been separately filed with the Securities and Exchange Commission. 12th January 2016 LDR Medical SAS Hotel de Bureaux 1, 4 rue Gustave Eiffel, 10430 Ros
May 10, 2016	EX-10.1	Rules of the LDR Holding Corporation 2013 Equity Incentive Plan For the Grant of Options, Performance Units and Restricted Stock Units to Participants in France SEC Exhibit EXHIBIT 10.1 Rules of the LDR Holding Corporation 2013 Equity Incentive Plan For the Grant of Options, Performance Units and Restricted Stock Units to Participants in France I. GENERAL PROVISIONS 1. Introduction The Board of Directors (the ?Board?) of LDR Holding Corporation (the ?Company?) has previously established the LDR Holding Corporation 2013 Equity Incentive Plan (the ?U.S. Pla
May 10, 2016	10-Q	LDR Holding FORM 10-Q (Quarterly Report) SEC Document Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.
May 10, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition SEC Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 10, 2016 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission
May 10, 2016	EX-99.1	LDR HOLDING CORPORATION REPORTS FIRST QUARTER 2016 RESULTS First Quarter Revenue Increased 8.4% Year-Over-Year to $42.4 million or 9.7% Constant Currency Global Mobi-C Growth of 28.8% Driven by U.S. Mobi-C Growth of 36.0% SEC Exhibit EXHIBIT 99.1 LDR HOLDING CORPORATION REPORTS FIRST QUARTER 2016 RESULTS First Quarter Revenue Increased 8.4% Year-Over-Year to $42.4 million or 9.7% Constant Currency Global Mobi-C Growth of 28.8% Driven by U.S. Mobi-C Growth of 36.0% AUSTIN, Texas, May 10, 2016 - LDR Holding Corporation (NASDAQ: LDRH), a global medical device company focused on designing and commercializing novel and
May 6, 2016	CORRESP	LDR Holding ESP CORRESP LDR Holding Corporation 13785 Research Boulevard, Suite 200 Austin, Texas 78750 May 6, 2016 VIA EDGAR Martin James Senior Assistant Chief Accountant Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.
May 6, 2016	CORRESP	LDR Holding ESP CORRESP Andrews Kurth LLP 111 Congress Avenue, Suite 1700 Austin, Texas 78701 +1.512.320.9200 Phone +1.512.320.9292 Fax andrewskurth.com May 6, 2016 VIA EDGAR Martin James Senior Assistant Chief Accountant Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: LDR Holding Corporation Form 10-K for the Year Ended December 31, 201
April 28, 2016	8-K	Submission of Matters to a Vote of Security Holders 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 28, 2016 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Nu
March 30, 2016	8-K	Regulation FD Disclosure 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 29, 2016 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Nu
March 10, 2016	DEFA14A	LDR Holding DEFINITIVE ADDITIONAL MATERIALS DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2))
March 10, 2016	DEF 14A	LDR Holding DEFINITIVE PROXY STATEMENT DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2))
February 23, 2016	EX-99.1	LDR Holding Corporation Analyst Day February 23, 2016 Matt Norman Director, Investor Relations 2 Forward Looking Statement & Disclaimer 3 LDR cautions that statements in this presentation (including the oral commentary that accompanies it) are forwar ldrinvestorpresentation2 LDR Holding Corporation Analyst Day February 23, 2016 Matt Norman Director, Investor Relations 2 Forward Looking Statement & Disclaimer 3 LDR cautions that statements in this presentation (including the oral commentary that accompanies it) are forward-looking statements.
February 23, 2016	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 23, 2016 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Num
February 23, 2016	EX-10.16	June 10, 2013 EXHIBIT 10.16 June 10, 2013 Joe Ross Re: EMPLOYMENT TERMS Dear Joe: LDR Holding Corporation (the “Company”) is pleased to offer to continue your employment as Executive Vice President - Global Marketing of the Company on the terms and conditions set forth in this letter, effective as of June 10, 2013 (the “Effective Date”). This letter amends and restates in its entirety any prior agreement you ha
February 23, 2016	EX-10.38	LDR Médical CONTRAT COMMERCIAL FOURNISSEUR Supply Agreement Réf. : CC FRN GB 02 Indice : 31/12/2015 AM n° : Page 1 sur 18 LDR Médical CONTRAT COMMERCIAL FOURNISSEUR Supply Agreement Réf. : CC FRN GB 02 Indice : 31/12/2015 AM n° : Page 1 sur 18 EXHIBIT 10.38 [***] indicates material that has been omitted pursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission. A complete copy of this agreement, including redacted portions so indicated, has been filed separately with the Secur
February 23, 2016	EX-10.17	June 10, 2013 EX-10.17 3 ex1017.htm EX-10.17 EXHIBIT 10.17 June 10, 2013 James Burrows Re: EMPLOYMENT TERMS Dear James: LDR Holding Corporation (the “Company”) is pleased to offer to continue your employment as Chief Operating Officer of the Company on the terms and conditions set forth in this letter, effective as of June 10, 2013 (the “Effective Date”). This letter amends and restates in its entirety any prio
February 23, 2016	EX-10.35	LDR HOLDING CORPORATION AMENDED AND RESTATED NON-EMPLOYEE INDEPENDENT DIRECTOR COMPENSATION POLICY Adopted on January 5, 2016 EXHIBIT 10.35 LDR HOLDING CORPORATION AMENDED AND RESTATED NON-EMPLOYEE INDEPENDENT DIRECTOR COMPENSATION POLICY Adopted on January 5, 2016 This sets forth the Second Amended and Restated Non-Employee Independent Director Compensation Policy (the “Policy”) of LDR Holding Corporation (the “Company”), as adopted by the Compensation Committee of the Board of Directors of the Company (the “Board”), wh
February 23, 2016	EX-10.18	June 10, 2013 EX-10.18 4 ex1018.htm EX-10.18 EXHIBIT 10.18 June 10, 2013 Scott Way Re: EMPLOYMENT TERMS Dear Scott: LDR Holding Corporation (the “Company”) is pleased to offer to continue your employment as Executive Vice President-General Counsel and Compliance Officer of the Company on the terms and conditions set forth in this letter, effective as of June 10, 2013 (the “Effective Date”). This letter amends a
February 22, 2016	S-8	LDR Holding Form S-8 As filed with the Securities and Exchange Commission on February 22, 2016 Registration No.
February 22, 2016	10-K	LDR Holding Form 10-K (Annual Report) 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.
February 17, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 17, 2016 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File
February 17, 2016	EX-99.1	LDR HOLDING CORPORATION REPORTS RECORD REVENUE FOR FOURTH QUARTER AND FISCAL YEAR 2015 Fiscal year revenue increased 16.4% year-over-year to $164.5 million or 21.3% constant currency Exhibit EXHIBIT 99.1 LDR HOLDING CORPORATION REPORTS RECORD REVENUE FOR FOURTH QUARTER AND FISCAL YEAR 2015 Fiscal year revenue increased 16.4% year-over-year to $164.5 million or 21.3% constant currency AUSTIN, Texas, February 17, 2016 - LDR Holding Corporation (NASDAQ: LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for
February 16, 2016	SC 13G/A	LDRH / LDR Holding Corp / Telegraph Hill Partners Management Company, LLC - SC 13G/A Passive Investment SC 13G/A 1 d145078dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* LDR Holding Corporation (Name of Issuer) $0.001 par value common stock (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appr
February 12, 2016	SC 13G/A	LDRH / LDR Holding Corp / GILDER GAGNON HOWE & CO LLC - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (Amendment No. 2)* LDR Holding Corporation (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2015 (Date o
February 11, 2016	SC 13G	LDRH / LDR Holding Corp / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* LDR HOLDING CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this
February 5, 2016	SC 13G	LDRH / LDR Holding Corp / Camber Capital Management LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 LDR Holding Corporation (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 50185U105 (CUSIP Number) January 26, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S
February 5, 2016	EX-1	JOINT FILING AGREEMENT EXHIBIT 1 JOINT FILING AGREEMENT This Joint Filing Agreement dated February 5, 2016 is by and between Camber Capital Management LLC, a Massachusetts limited liability company, and Stephen DuBois, an individual (the foregoing are collectively referred to herein as the "Filers").
January 20, 2016	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 20, 2016 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Numb
November 4, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q 10-Q 1 form10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period f
November 4, 2015	8-K	LDR Holding FORM 8-K (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 4, 2015 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File
November 4, 2015	EX-99.1	LDR HOLDING CORPORATION REPORTS THIRD QUARTER 2015 RESULTS Third quarter revenue increased 9.5% year-over-year to $39.3 million or 14.2% constant currency Exhibit EXHIBIT 99.1 LDR HOLDING CORPORATION REPORTS THIRD QUARTER 2015 RESULTS Third quarter revenue increased 9.5% year-over-year to $39.3 million or 14.2% constant currency AUSTIN, Texas, November 4, 2015 - LDR Holding Corporation (NASDAQ: LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suf
October 13, 2015	8-K	LDR Holding FORM 8-K (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 8, 2015 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File N
October 13, 2015	EX-10.1	SECOND AMENDMENT TO LEASE AGREEMENT Exhibit EXHIBIT 10.1 SECOND AMENDMENT TO LEASE AGREEMENT This Second Amendment to Lease Agreement (this " Amendment ") is entered into as of October 8, 2015 (the " Effective Date ") by and between FPG ASPEN LAKE OWNER, LP , a Delaware limited partnership (as successor-in-interest to 13785 Research Blvd, LLC, a Texas limited liability company) (the " Landlord "), as landlord, and LDR SPINE USA, INC
October 8, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 8, 2015 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File N
October 8, 2015	EX-99.1	LDR HOLDING CORPORATION ANNOUNCES PRELIMINARY REVENUE RESULTS FOR THIRD QUARTER 2015 Exhibit EXHIBIT 99.1 LDR HOLDING CORPORATION ANNOUNCES PRELIMINARY REVENUE RESULTS FOR THIRD QUARTER 2015 AUSTIN, Texas, October 8, 2015 - LDR Holding Corporation (NASDAQ: LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced preliminary estimated reve
August 14, 2015	424B5	The date of this prospectus supplement is August 13, 2015. 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-199882 PROSPECTUS SUPPLEMENT (To Prospectus dated December 9, 2014) 2,000,000 Shares LDR HOLDING CORPORATION Common Stock $40.00 per share We are offering 2,000,000 shares of our common stock. Our common stock is listed on the NASDAQ Global Select Market, or NASDAQ, under the trading symbol ?LDRH.? On August 12, 2015, th
August 14, 2015	EX-1.1	2,000,000 Shares LDR Holding Corporation Common Stock PURCHASE AGREEMENT Exhibit EXHIBIT 1.1 EXECUTION VERSION 2,000,000 Shares LDR Holding Corporation Common Stock PURCHASE AGREEMENT August 13, 2015 PIPER JAFFRAY & CO. As Representative of the several Underwriters named in Schedule I hereto c/o Piper Jaffray & Co. U.S. Bancorp Center 800 Nicollet Mall Minneapolis, Minnesota 55402 Ladies and Gentlemen: LDR Holding Corporation, a Delaware corporation (the ? Company? ),
August 14, 2015	EX-1.1	2,000,000 Shares LDR Holding Corporation Common Stock PURCHASE AGREEMENT Exhibit EXHIBIT 1.1 EXECUTION VERSION 2,000,000 Shares LDR Holding Corporation Common Stock PURCHASE AGREEMENT August 13, 2015 PIPER JAFFRAY & CO. As Representative of the several Underwriters named in Schedule I hereto c/o Piper Jaffray & Co. U.S. Bancorp Center 800 Nicollet Mall Minneapolis, Minnesota 55402 Ladies and Gentlemen: LDR Holding Corporation, a Delaware corporation (the ? Company? ),
August 14, 2015	8-K/A	LDR Holding FORM 8-K/A (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 13, 2015 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File
August 14, 2015	8-K	LDR Holding FORM 8-K (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 13, 2015 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File N
August 12, 2015	8-K	LDR Holding FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 12, 2015 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-36095 20-3933262 (State or Other Jurisdiction of Incorporation) (C
August 12, 2015	EX-99.1	VerteBRIDGE Products – Cervical VerteBRIDGE Products – Lumbar Spine EX-99.1 Exhibit 99.1 In this filing, unless the context otherwise requires, references to ?LDR Holding Corporation,? ?LDR?, ?we?, ?our,? ?us,? and the ?company? refer to LDR Holding Corporation together with its subsidiaries. BUSINESS Overview We are a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients su
August 12, 2015	424B5	Subject to completion, dated August 12, 2015 424B5 Table of Contents The information in this preliminary prospectus supplement is not complete and may be changed.
August 5, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition Form 8K Q2 2015 ER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
August 5, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001
August 5, 2015	EX-99.1	LDR HOLDING CORPORATION REPORTS SECOND QUARTER 2015 RESULTS Second quarter revenue increased 19.4% year-over-year to $41.5 million or 25.5% constant currency EXHIBIT 99.1 LDR HOLDING CORPORATION REPORTS SECOND QUARTER 2015 RESULTS Second quarter revenue increased 19.4% year-over-year to $41.5 million or 25.5% constant currency AUSTIN, Texas, August 5, 2015 - LDR Holding Corporation (NASDAQ: LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering
July 28, 2015	CORRESP	LDR Holding ESP 2015.07 SEC Comment Tandy Letter LDR Holding Corporation 13785 Research Boulevard, Suite 200 Austin, Texas 78750 July 28, 2015 VIA EDGAR Martin James Senior Assistant Chief Accountant Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: LDR Holding Corporation Form 10-K for the Year Ended December 31, 2014 Filed February 20, 2
July 28, 2015	CORRESP	LDR Holding ESP 2015.07 SEC Comment Letter Andrews Kurth LLP 111 Congress Avenue, Suite 1700 Austin, Texas 78701 +1.512.320.9200 Phone +1.512.320.9292 Fax andrewskurth.com Carmelo Gordion +1.512.320.9290 Phone [email protected] July 28, 2015 VIA EDGAR Martin James Senior Assistant Chief Accountant Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Was
July 9, 2015	EX-99.1	LDR HOLDING APPOINTS ALAN MILINAZZO TO BOARD OF DIRECTORS 8K 2015.07.09 Exhibit 99.1 EXHIBIT 99.1 LDR HOLDING APPOINTS ALAN MILINAZZO TO BOARD OF DIRECTORS Mr. Milinazzo Brings Over 25 years of Experience in the Life Science Sector AUSTIN, Texas, July 9, 2015 (GLOBE NEWSWIRE) - LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of pa
July 9, 2015	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 9, 2015 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Number)
May 7, 2015	8-K	LDR Holding FORM 8-K (Current Report/Significant Event) Form 8K 2015.05.07 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 7, 2015 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commis
May 6, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q 10-Q 1 form10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from
May 6, 2015	EX-10.1	COMMERICAL LEASE FOR A BUILDING FOR FUTURE COMPLETION (BEFA) BY AND BETWEEN LDR MEDICAL COMMERICAL LEASE FOR A BUILDING FOR FUTURE COMPLETION (BEFA) BY AND BETWEEN CIRMAD AND LDR MEDICAL 1 COMMERCIAL LEASE Governed by the provisions of Articles L.
May 6, 2015	8-K	LDR Holding FORM 8-K (Current Report/Significant Event) 2015 Q1 ER 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 6, 2015 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-36095 (Commission
May 6, 2015	EX-99.1	LDR HOLDING CORPORATION REPORTS FIRST QUARTER 2015 RESULTS First quarter revenue increased 25.9% year-over-year to $39.1 million 2015 Q1 Earnings Release EXHIBIT 99.1 LDR HOLDING CORPORATION REPORTS FIRST QUARTER 2015 RESULTS First quarter revenue increased 25.9% year-over-year to $39.1 million AUSTIN, Texas, May 6, 2015 - LDR Holding Corporation (NASDAQ: LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from sp
March 18, 2015	DEFA14A	LDR Holding DEFINITIVE ADDITIONAL MATERIALS Proxy 2015 Additional Materials UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 18, 2015	DEF 14A	LDR Holding DEFINITIVE PROXY STATEMENT Proxy 2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(
March 10, 2015	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 6, 2015 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Number)
February 20, 2015	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-K 10-K 1 form10k.htm FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Co
February 20, 2015	S-8	LDRH / LDR Holding Corp S-8 - - S-8 As filed with the Securities and Exchange Commission on February 20, 2015 Registration No.
February 20, 2015	EX-10.9	LDR HOLDING CORPORATION RESTRICTED STOCK UNITS AGREEMENT EXHIBIT 10.9 LDR HOLDING CORPORATION RESTRICTED STOCK UNITS AGREEMENT LDR Holding Corporation has granted to the Participant named in the Notice of Grant of Restricted Stock Units (the “Grant Notice”) to which this Restricted Stock Units Agreement (the “Agreement”) is attached an Award consisting of Restricted Stock Units subject to the terms and conditions set forth in the Grant Notice and this A
February 20, 2015	EX-10.31	LDR HOLDING CORPORATION AMENDED AND RESTATED NON-EMPLOYEE INDEPENDENT DIRECTOR COMPENSATION POLICY Adopted on February 18, 2015 EXHIBIT 10.31 LDR HOLDING CORPORATION AMENDED AND RESTATED NON-EMPLOYEE INDEPENDENT DIRECTOR COMPENSATION POLICY Adopted on February 18, 2015 This sets forth the Amended and Restated Non-employee Independent Director Compensation Policy (the “Policy”) of LDR Holding Corporation (the “Company”), as adopted by the Compensation Committee of the Board of Directors of the Company (the “Board”), which s
February 20, 2015	EX-10.10	LDR HOLDING CORPORATION PERFORMANCE-BASED RESTRICTED STOCK UNITS AGREEMENT EXHIBIT 10.10 LDR HOLDING CORPORATION PERFORMANCE-BASED RESTRICTED STOCK UNITS AGREEMENT LDR Holding Corporation has granted to the Participant named in the Notice of Grant of Performance-Based Restricted Stock Units (the “Grant Notice”) to which this Performance-Restricted Stock Units Agreement (the “Agreement”) is attached an Award consisting of Restricted Stock Units subject to the terms and co
February 20, 2015	EX-10.7	LDR HOLDING CORPORATION STOCK OPTION AGREEMENT EXHIBIT 10.7 LDR HOLDING CORPORATION STOCK OPTION AGREEMENT The LDR Holding Corporation (the “Company”) has granted to the Participant named in the Notice of Grant of Stock Option (the “Grant Notice”) to which this Stock Option Agreement (the “Option Agreement”) is attached an option (the “Option”) to purchase certain shares of Stock upon the terms and conditions set forth in the Grant Notice and
February 20, 2015	EX-10.32	Confidential Page 1 of 44 EX-10.32 6 ex1032.htm EX-10.32 EXHIBIT 10.32 [***] indicates material that has been omitted pursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission. A complete copy of this agreement, including redacted portions so indicated, has been filed separately with the Securities Exchange Commission. 837.1 THIS AGREEMENT is made on 26th November 2014 BETWEEN: (1)
February 18, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 18, 2015 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Num
February 18, 2015	EX-99.1	LDR HOLDING CORPORATION REPORTS FOURTH QUARTER AND FISCAL YEAR 2014 RESULTS Fourth quarter revenue increased 23.6% year-over-year to $39.5 million EXHIBIT 99.1 LDR HOLDING CORPORATION REPORTS FOURTH QUARTER AND FISCAL YEAR 2014 RESULTS Fourth quarter revenue increased 23.6% year-over-year to $39.5 million AUSTIN, Texas, February 18, 2015 - LDR Holding Corporation (NASDAQ: LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spi
February 17, 2015	SC 13G/A	LDRH / LDR Holding Corp / AUSTIN VENTURES VIII LP - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b) (Amendment No. 1)* LDR Holding Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of thi
February 10, 2015	SC 13G/A	LDRH / LDR Holding Corp / GILDER GAGNON HOWE & CO LLC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 v400859sc13ga.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (Amendment No. 1)* LDR Holding Corporation (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 50185U
January 26, 2015	SC 13G/A	LDR Holding SC 13G/A (Passive Acquisition of More Than 5% of Shares) Dinville 13G 1.2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* LDR Holding Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate
January 26, 2015	SC 13G/A	LDR Holding SC 13G/A (Passive Acquisition of More Than 5% of Shares) Lavigne 13G 1.2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* LDR Holding Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate b
January 26, 2015	SC 13G/A	LDRH / LDR Holding Corp / Telegraph Hill Partners Management Company, LLC - SCHEDULE 13G (AMENDMENT NO. 1) Passive Investment Schedule 13G (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* LDR Holding Corporation (Name of Issuer) $0.001 par value common stock (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate
January 23, 2015	SC 13G/A	LDRH / LDR Holding Corp / Keensight Capital - SC 13G (AMENDMENT NO. 1) Passive Investment SC 13G/A 1 d857374dsc13ga.htm SC 13G (AMENDMENT NO. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* LDR Holding Corporation (Name of Issuer) $0.001 par value common stock (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement
January 16, 2015	SC 13G/A	LDRH / LDR Holding Corp / PTV SCIENCES II L P - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* LDR Holding Corporation (Name of Issuer) $0.001 par value common stock (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r
December 10, 2014	424B3	LDR HOLDING CORPORATION Common Stock Preferred Stock Debt Securities 2,508,092 Shares of Common Stock Offered by Selling Securityholders Final Prospectus Table of Contents Filed Pursuant to Rule 424(b)(3) Registration Number 333-199882 PROSPECTUS LDR HOLDING CORPORATION $150,000,000 Common Stock Preferred Stock Debt Securities Warrants 2,508,092 Shares of Common Stock Offered by Selling Securityholders We may offer and sell, from time to time, in one or more series or issuances and on terms that we will determine at the time of the offering, any combination of the securities described in this prospectus, up to an aggregate amount of $150,000,000.
December 5, 2014	CORRESP	LDRH / LDR Holding Corp CORRESP - - Acceleration Request December 5, 2014 VIA EDGAR Mary Beth Breslin U.S. Securities and Exchange Commission Division of Corporation Finance Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 RE: LDR Holding Corporation Registration Statement on Form S-3 File Number 333-199882 Dear Ms. Breslin: In accordance with Rule 461 under the Securities Act of 1933, as amended, the under
December 3, 2014	EX-12.1	STATEMENT OF COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES AND RATIO OF EARNINGS TO FIXED CHARGES AND PREFERRED STOCK DIVIDENDS EX-12.1 Exhibit 12.1 STATEMENT OF COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES AND RATIO OF EARNINGS TO FIXED CHARGES AND PREFERRED STOCK DIVIDENDS The following table sets forth our ratio of earnings to fixed charges and the ratio of our earnings to combined fixed charges and preferred stock dividends to earnings for each of the years ended December 31, 2013, 2012 and 2011, and for the nine
December 3, 2014	EX-4.4	LDR HOLDING CORPORATION [ ] DATED AS OF , 20 SUBORDINATED DEBT SECURITIES LDR HOLDING CORPORATION RECONCILIATION AND TIE BETWEEN TRUST INDENTURE ACT OF 1939, AS AMENDED, AND INDENTURE, DATED AS OF , 20 TRUST INDENTURE ACT SECTION INDENTURE SECTION Se EX-4.4 EXHIBIT 4.4 LDR HOLDING CORPORATION AND [ ] Trustee INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES LDR HOLDING CORPORATION RECONCILIATION AND TIE BETWEEN TRUST INDENTURE ACT OF 1939, AS AMENDED, AND INDENTURE, DATED AS OF , 20 TRUST INDENTURE ACT SECTION INDENTURE SECTION Section 310(a)(1) 6.9 (a)(2) 6.9 (a)(3) Not Applicable (a)(4) Not Applicable (a)(5) 6.9 (b) 6.8 Section 311 6.1
December 3, 2014	S-3/A	LDRH / LDR Holding Corp S-3/A - - AMENDMENT NO. 1 TO FORM S-3 Amendment No. 1 to Form S-3 Table of Contents As filed with the Securities and Exchange Commission on December 3, 2014 Registration No. 333-199882 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to Form S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 LDR Holding Corporation (Exact name of registrant as specified in its charter) Delaware (State or
December 3, 2014	EX-4.3	LDR HOLDING CORPORATION [ ] DATED AS OF , 20 SENIOR DEBT SECURITIES LDR HOLDING CORPORATION RECONCILIATION AND TIE BETWEEN TRUST INDENTURE ACT OF 1939, AS AMENDED, AND INDENTURE, DATED AS OF , 20 TRUST INDENTURE ACT SECTION INDENTURE SECTION Section EX-4.3 EXHIBIT 4.3 LDR HOLDING CORPORATION AND [ ] Trustee INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES LDR HOLDING CORPORATION RECONCILIATION AND TIE BETWEEN TRUST INDENTURE ACT OF 1939, AS AMENDED, AND INDENTURE, DATED AS OF , 20 TRUST INDENTURE ACT SECTION INDENTURE SECTION Section 310(a)(1) 6.9 (a)(2) 6.9 (a)(3) Not Applicable (a)(4) Not Applicable (a)(5) 6.9 (b) 6.8 Section 311 6.13 Sect
December 3, 2014	CORRESP	LDRH / LDR Holding Corp CORRESP - - Response Letter 111 Congress Avenue, Suite 1700 Austin, Texas 78701 512.320.9200 Phone 512.320.9292 Fax andrewskurth.com December 3, 2014 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington D.C. 20549-4561 Mail Stop 4561 RE: LDR Holding Corporation Registration Statement on Form S-3 Filed on November 5, 2014 File No. 333-199882 Ladies and Gent
December 1, 2014	8-K	Entry into a Material Definitive Agreement 8-K 1 form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 26, 2014 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-
November 14, 2014	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 13, 2014 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Num
November 14, 2014	EX-99.1	LDR ANNOUNCES PRESENTATIONS OF MOBI-C® CERVICAL DISC FIVE-YEAR CLINICAL RESULTS AT THE NORTH AMERICAN SPINE SOCIETY ANNUAL MEETING (NASS) Represents the first public view of long-term data for Mobi-C, the only cervical disc FDA approved for both one Media Contact: Jon Stone [email protected] (646) 747-7161 LDR ANNOUNCES PRESENTATIONS OF MOBI-C® CERVICAL DISC FIVE-YEAR CLINICAL RESULTS AT THE NORTH AMERICAN SPINE SOCIETY ANNUAL MEETING (NASS) Represents the first public view of long-term data for Mobi-C, the only cervical disc FDA approved for both one and two-level indications AUSTIN, TEXAS - November 13, 2014 - LDR Holding Corporation (NAS
November 14, 2014	EX-99.2	Mobi-C® 5 Year 1 and 2 Level IDE Study Results 2 • Prospective, randomized, multi-center concurrently controlled, FDA IDE clinical trial: – Investigational device: Mobi-C® Cervical Disc. – Control: ACDF. – Non-inferiority study with 2:1 randomization mobic5year12levelsummary Mobi-C® 5 Year 1 and 2 Level IDE Study Results 2 • Prospective, randomized, multi-center concurrently controlled, FDA IDE clinical trial: – Investigational device: Mobi-C® Cervical Disc.
November 6, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q 10-Q 1 form10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period f
November 5, 2014	EX-12.1	STATEMENT OF COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES AND RATIO OF EARNINGS TO FIXED CHARGES AND PREFERRED STOCK DIVIDENDS EX-12.1 Exhibit 12.1 STATEMENT OF COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES AND RATIO OF EARNINGS TO FIXED CHARGES AND PREFERRED STOCK DIVIDENDS The following table sets forth our ratio of earnings to fixed charges and the ratio of our earnings to combined fixed charges and preferred stock dividends to earnings for each of the years ended December 31, 2013, 2012 and 2011, and for the six m
November 5, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 5, 2014 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Numb
November 5, 2014	S-3	LDRH / LDR Holding Corp S-3 - - FORM S-3 Form S-3 Table of Contents As filed with the Securities and Exchange Commission on November 5, 2014 Registration No.
November 5, 2014	EX-99.1	LDR HOLDING CORPORATION REPORTS THIRD QUARTER 2014 RESULTS Third quarter revenue increased 32.0% year-over-year to $35.9 million EXHIBIT 99.1 LDR HOLDING CORPORATION REPORTS THIRD QUARTER 2014 RESULTS Third quarter revenue increased 32.0% year-over-year to $35.9 million AUSTIN, Texas, November 5, 2014 - LDR Holding Corporation (NASDAQ: LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today
September 29, 2014	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 29, 2014 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Nu
September 29, 2014	EX-10.1	Invibio® biomedical solutions Invibio LTD Technology Centre Hillhouse International Thornton Cleveleys. Lancashire FY5 4QD UK Tel. +44 (0)1253 866812 Tel +44 (0)1253 851458 [email protected] www.invibio.com EXHIBIT 10.1 Invibio® biomedical solutions Invibio LTD Technology Centre Hillhouse International Thornton Cleveleys. Lancashire FY5 4QD UK Tel. +44 (0)1253 866812 Tel +44 (0)1253 851458 [email protected] www.invibio.com 29th September 2014 LDR Medical Technopole de L'Aube BP 2-10 902 Troyes cedex 9 France Dear Sirs, Letter of Amendment in respect of Supply Agreement between Invibio Ltd. and LDR Med
August 27, 2014	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 27, 2014 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-36
August 27, 2014	EX-10.1	Invibio® biomedical solutions Invibio LTD Technology Centre Hillhouse International Thornton Cleveleys. Lancashire FY5 4QD UK Tel. +44 (0)1253 866812 Tel +44 (0)1253 851458 [email protected] www.invibio.com EXHIBIT 10.1 Invibio® biomedical solutions Invibio LTD Technology Centre Hillhouse International Thornton Cleveleys. Lancashire FY5 4QD UK Tel. +44 (0)1253 866812 Tel +44 (0)1253 851458 [email protected] www.invibio.com 22nd August 2014 LDR Medical Technopole de L'Aube BP 2-10 902 Troyes cedex 9 France Dear Sirs, Letter of Amendment in respect of Supply Agreement between Invibio Ltd. and LDR Medica
August 7, 2014	EX-10.1	LDR HOLDING CORPORATION AMENDED AND RESTATED NON-EMPLOYEE INDEPENDENT DIRECTOR COMPENSATION POLICY EXHIBIT 10.1 US:683320.1 LDR HOLDING CORPORATION AMENDED AND RESTATED NON-EMPLOYEE INDEPENDENT DIRECTOR COMPENSATION POLICY This sets forth the Amended and Restated Non-employee Independent Director Compensation Policy (the “Policy”) of LDR Holding Corporation (the “Company”), as adopted by the Compensation Committee of the Board of Directors of the Company (the “Board”), which shall remain in eff
August 7, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q 10-Q 1 form10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from t
August 6, 2014	EX-99.1	LDR HOLDING CORPORATION REPORTS SECOND QUARTER 2014 RESULTS Second quarter revenue increased 30.7% year-over-year to $34.8 million EXHIBIT 99.1 LDR HOLDING CORPORATION REPORTS SECOND QUARTER 2014 RESULTS Second quarter revenue increased 30.7% year-over-year to $34.8 million AUSTIN, Texas, August 6, 2014 - LDR Holding Corporation (NASDAQ: LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today
August 6, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 6, 2014 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Number
July 25, 2014	EX-10.1	Invibio® biomedical solutions Invibio LTD Technology Centre Hillhouse International Thornton Cleveleys. Lancashire FY5 4QD UK Tel. +44 (0)1253 866812 Tel +44 (0)1253 851458 [email protected] www.invibio.com EXHIBIT 10.1 Invibio® biomedical solutions Invibio LTD Technology Centre Hillhouse International Thornton Cleveleys. Lancashire FY5 4QD UK Tel. +44 (0)1253 866812 Tel +44 (0)1253 851458 [email protected] www.invibio.com 17th July 2014 LDR Medical Technopole de L'Aube BP 2-10 902 Troyes cedex 9 France Dear Sirs, Letter of Amendment in respect of Supply Agreement between Invibio Ltd. and LDR Medical
July 25, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 24, 2014 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Number)
June 4, 2014	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 3, 2014 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Number)
May 16, 2014	EX-99.1	LDR Announces Pricing of Follow-On Offering EX-99.1 Exhibit 99.1 LDR Announces Pricing of Follow-On Offering AUSTIN, Texas, May 14, 2014 (GLOBE NEWSWIRE)—LDR Holding Corporation (Nasdaq:LDRH) (“LDR” or the “Company”), a global medical device company focused on designing and commercializing novel and proprietary spinal surgical technologies, today announced the pricing of a follow-on offering of 3,972,089 shares of its common stock at a pric
May 16, 2014	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 14, 2014 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-36095 20-3933262 (State or Other Jurisdiction of Incorporation) (Commissio
May 16, 2014	EX-1.1	3,972,089 Shares LDR Holding Corporation Common Stock PURCHASE AGREEMENT EX-1.1 2 d730885dex11.htm EX-1.1 Exhibit 1.1 Execution Version 3,972,089 Shares LDR Holding Corporation Common Stock PURCHASE AGREEMENT May 14, 2014 PIPER JAFFRAY & CO. As Representative of the several Underwriters named in Schedule II hereto c/o Piper Jaffray & Co. 800 Nicollet Mall Minneapolis, Minnesota 55402 Ladies and Gentlemen: LDR Holding Corporation, a Delaware corporation (the “Company”),
May 15, 2014	424B4	The date of this prospectus is May 14, 2014. Final Prospectus Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No.
May 14, 2014	S-1MEF	- S-1MEF S-1MEF As filed with the Securities and Exchange Commission on May 14, 2014 Registration No.
May 12, 2014	EX-1.1	[ — ] Shares LDR Holding Corporation Common Stock PURCHASE AGREEMENT EX-1.1 Exhibit 1.1 [ — ] Shares LDR Holding Corporation Common Stock PURCHASE AGREEMENT [ — ], 2014 PIPER JAFFRAY & CO. As Representative of the several Underwriters named in Schedule II hereto c/o Piper Jaffray & Co. 800 Nicollet Mall Minneapolis, Minnesota 55402 Ladies and Gentlemen: LDR Holding Corporation, a Delaware corporation (the “Company”), and the stockholders of the Company listed in Sc
May 12, 2014	S-1/A	- AMENDMENT NO. 2 TO FORM S-1 Amendment No. 2 to Form S-1 Table of Contents As filed with the Securities and Exchange Commission on May 12, 2014 Registration No. 333-194994 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO Form S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 LDR Holding Corporation (Exact name of registrant as specified in its charter) Delaware 3841 20-39332
May 7, 2014	EX-10.1	SEVENTH AMENDMENT TO LOAN AND SECURITY AGREEMENT EXHIBIT 10.1 SEVENTH AMENDMENT TO LOAN AND SECURITY AGREEMENT This Seventh Amendment to Loan and Security Agreement (this "Amendment") is entered into as of May 5, 2014, to be effective as of April 24, 2014, by and among COMERICA BANK ("Bank") and LDR HOLDING CORPORATION, a Delaware corporation, and LDR SPINE USA, INC., a Delaware corporation (each a "Borrower", and collectively, "Borrowers"). REC
May 7, 2014	EX-10.1	SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENT EXHIBIT 10.1 SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENT This Sixth Amendment to Loan and Security Agreement (this “Amendment”) is entered into as of December 20, 2012, by and among COMERICA BANK (“Bank”) and LDR HOLDING CORPORATION, a Delaware corporation, and LDR SPINE USA, INC., a Delaware corporation (each a “Borrower”, and collectively, “Borrowers”). RECITALS Borrowers and Bank are parties
May 7, 2014	EX-99.1	LDR HOLDING CORPORATION REPORTS FIRST QUARTER 2014 RESULTS First quarter revenue increased 20.2% year-over-year to $31.1 million EXHIBIT 99.1 LDR HOLDING CORPORATION REPORTS FIRST QUARTER 2014 RESULTS First quarter revenue increased 20.2% year-over-year to $31.1 million AUSTIN, Texas, May 7, 2014 - LDR Holding Corporation (NASDAQ: LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today repo
May 7, 2014	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 5, 2014 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Number) 2
May 7, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 00
April 24, 2014	DEFA14A	- DEFINITIVE ADDITIONAL MATERIALS DEFA14A 1 ldr2014defa14a.htm DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for use of t
April 24, 2014	DEF 14A	- DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) þ Defin
April 11, 2014	EX-10.1	LDR HOLDING CORPORATION SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT April 7, 2014 TABLE OF CONTENTS 1. Registration Rights 2 1.1 Definitions 2 1.2 Request for Registration 3 1.3 Company Registration 4 1.4 Obligations of the Company 5 1.5 EX-10.1 2 ex-101.htm EX-10.1 Exhibit 10.1 AUS:676983.4 AUS:676983.4 LDR HOLDING CORPORATION SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT April 7, 2014 TABLE OF CONTENTS 1. Registration Rights 2 1.1 Definitions 2 1.2 Request for Registration 3 1.3 Company Registration 4 1.4 Obligations of the Company 5 1.5 Furnish Information 6 1.6 Expenses of Demand Registration 7 1.7 Expenses of Compan
April 11, 2014	S-1/A	- AMENDMENT NO. 1 TO FORM S-1 Amendment No. 1 to Form S-1 Table of Contents As filed with the Securities and Exchange Commission on April 11, 2014 Registration No. 333-194994 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO Form S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 LDR Holding Corporation (Exact name of registrant as specified in its charter) Delaware 3841 20-393
April 11, 2014	EX-1.1	[ — ] Shares LDR Holding Corporation Common Stock PURCHASE AGREEMENT EX-1.1 Exhibit 1.1 [ — ] Shares LDR Holding Corporation Common Stock PURCHASE AGREEMENT [ — ], 2014 PIPER JAFFRAY & CO. As Representative of the several Underwriters named in Schedule II hereto c/o Piper Jaffray & Co. 800 Nicollet Mall Minneapolis, Minnesota 55402 Ladies and Gentlemen: LDR Holding Corporation, a Delaware corporation (the “Company”), and the stockholders of the Company listed in Sc
April 11, 2014	EX-99.1	LDR HOLDING CORPORATION ISSUES PRELIMINARY RESULTS FOR FIRST QUARTER 2014 Exhibit 99.1 LDR HOLDING CORPORATION ISSUES PRELIMINARY RESULTS FOR FIRST QUARTER 2014 AUSTIN, Texas, April 11, 2014 - LDR Holding Corporation (NASDAQ: LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced preliminary estimated financial results for th
April 11, 2014	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 7, 2014 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Number)
April 2, 2014	S-1	Registration Statement - FORM S-1 Form S-1 Table of Contents As filed with the Securities and Exchange Commission on April 2, 2014 Registration No.
March 5, 2014	S-8	- S-8 As filed with the Securities and Exchange Commission on March 5, 2014 Registration No.
March 4, 2014	EX-10.7	LDR HOLDING CORPORATION RESTRICTED STOCK UNITS AGREEMENT EXHIBIT 10.7 LDR HOLDING CORPORATION RESTRICTED STOCK UNITS AGREEMENT LDR Holding Corporation has granted to the Participant named in the Notice of Grant of Restricted Stock Units (the “Grant Notice”) to which this Restricted Stock Units Agreement (the “Agreement”) is attached an Award consisting of Restricted Stock Units subject to the terms and conditions set forth in the Grant Notice and this A
March 4, 2014	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year period ended December 31, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number:
March 4, 2014	EX-10.5	LDR HOLDING CORPORATION STOCK OPTION AGREEMENT EX-10.5 2 ldr10kexhibit105.htm EX-10.5 EXHIBIT 10.5 LDR HOLDING CORPORATION STOCK OPTION AGREEMENT The LDR Holding Corporation (the “Company”) has granted to the Participant named in the Notice of Grant of Stock Option (the “Grant Notice”) to which this Stock Option Agreement (the “Option Agreement”) is attached an option (the “Option”) to purchase certain shares of Stock upon the terms and condit
February 27, 2014	EX-99.1	LDR HOLDING CORPORATION REPORTS FOURTH QUARTER AND FISCAL YEAR 2013 RESULTS Fourth quarter revenue increased 28.1% year-over-year to $32.0 million Exhibit 99.1 LDR HOLDING CORPORATION REPORTS FOURTH QUARTER AND FISCAL YEAR 2013 RESULTS Fourth quarter revenue increased 28.1% year-over-year to $32.0 million AUSTIN, Texas, February 27, 2014 - LDR Holding Corporation (NASDAQ: LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spi
February 27, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 27, 2014 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Num
February 14, 2014	SC 13G	LDRH / LDR Holding Corp / Lavigne Christophe - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* LDR Holding Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r
February 14, 2014	SC 13G	LDRH / LDR Holding Corp / Dinville Herve - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* LDR Holding Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r
February 14, 2014	SC 13G	LDRH / LDR Holding Corp / Telegraph Hill Partners Management Company, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* LDR Holding Corporation (Name of Issuer) $0.001 par value common stock (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuan
February 13, 2014	SC 13G	LDRH / LDR Holding Corp / AUSTIN VENTURES VIII LP - SC 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b) (Amendment No. )* LDR Holding Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this
February 12, 2014	SC 13G	LDRH / LDR Holding Corp / GILDER GAGNON HOWE & CO LLC - FEBRUARY 12, 2014 Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (Amendment No. )* LDR Holdings Corporation (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2013 (Date of
February 11, 2014	SC 13G	LDRH / LDR Holding Corp / PTV SCIENCES II L P Passive Investment SC 13G 1 c27140sc13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* LDR Holding Corporation (Name of Issuer) $0.001 par value common stock (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d
February 4, 2014	SC 13G	LDRH / LDR Holding Corp / Keensight Capital - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* LDR Holding Corporation (Name of Issuer) $0.001 par value common stock (Title of Class of Securities) 50185U105 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua
December 27, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Unregistered Sales of Equity Securities - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 20, 2013 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Num
December 19, 2013	8-K/A	Financial Statements and Exhibits - 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 6, 2013 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Nu
December 19, 2013	EX-10.1	1st AMENDMENT TO THE SALES CONTRACT Exhibit 10.1 [***] indicates material that has been omitted pursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission. A complete copy of this agreement, including redacted portions so indicated, has been filed separately with the Securities Exchange Commission. 1st AMENDMENT TO THE SALES CONTRACT Between the undersigned LDR MEDICAL, a French company, with
December 12, 2013	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 6, 2013 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Numb
November 7, 2013	8-K	Regulation FD Disclosure - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 6, 2013 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Numb
November 7, 2013	EX-3.2	AMENDED AND RESTATED BYLAWS OF LDR HOLDING CORPORATION, a Delaware corporation (initially adopted on September 12, 2013 to be effective upon the closing of the Corporation’s initial public offering) AMENDED AND RESTATED BYLAWS OF LDR HOLDING CORPORATION, a Delaware corporation (initially adopted on September 12, 2013 to be effective upon the closing of the Corporation’s initial public offering) -1- Table of Contents Article I CORPORATE OFFICES 1 1.
November 7, 2013	EX-3.1	LDR HOLDING CORPORATION AMENDED AND RESTATED CERTIFICATE OF INCORPORATION EX-3.1 2 ldr20130930ex31.htm EX-3.1 EXHIBIT 3.1 LDR HOLDING CORPORATION AMENDED AND RESTATED CERTIFICATE OF INCORPORATION LDR Holding Corporation (the “Corporation”), a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify: FIRST: That the Corporation was originally incorporated pursuant to
November 7, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q 10-Q 1 ldr2013093010q.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period
November 6, 2013	EX-99.1	Mobi-C® CERVICAL DISC IDE Clinical Trial Overview Mobi-C Compared to Anterior Cervical Discectomy and Fusion at One-level key triAl results Mobi-C demonstrated non-inferiority in overall trial success compared to ACDF at 24 months. At 24 months, Mobi mobiconelevelstudydata Mobi-C® CERVICAL DISC IDE Clinical Trial Overview Mobi-C Compared to Anterior Cervical Discectomy and Fusion at One-level key triAl results Mobi-C demonstrated non-inferiority in overall trial success compared to ACDF at 24 months.
November 6, 2013	EX-99.3	1 and 2-Level US IDE Patient Population Summary Confidential 1 Total Enrolled: 627 Withdrew prior to surgery: 28 Total Operated: 599 Patients One Level • 164 Randomized Mobi-C • 81 Randomized ACDF • 15 Training Mobi-C Two Level • 225 Randomized Mobi- mobic48monthdata 1 and 2-Level US IDE Patient Population Summary Confidential 1 Total Enrolled: 627 Withdrew prior to surgery: 28 Total Operated: 599 Patients One Level • 164 Randomized Mobi-C • 81 Randomized ACDF • 15 Training Mobi-C Two Level • 225 Randomized Mobi-C • 105 Randomized ACDF • 9 Training Mobi-C 1 Level US IDE Study Secondary Surgery Rates Compared to ACDF through 4 Years Confidential 2 1 Level Secondary Surgeries 1.
November 6, 2013	EX-99.1	LDR HOLDING CORPORATION REPORTS THIRD QUARTER 2013 RESULTS Revenue increased 29.8% year-over-year to $27.2 million Exhibit 99.1 LDR HOLDING CORPORATION REPORTS THIRD QUARTER 2013 RESULTS Revenue increased 29.8% year-over-year to $27.2 million AUSTIN, Texas, November 6, 2013 - LDR Holding Corporation (NASDAQ: LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today reported its
November 6, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 6, 2013 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Numb
November 6, 2013	EX-99.2	Mobi-C® CERVICAL DISC IDE Clinical Trial Overview Mobi-C Compared to Anterior Cervical Discectomy and Fusion at Two Contiguous Levels Mobi-C® demonstrated superiority in overall trial success compared to ACDF at two-levels key TriAL resuLTs Mobi-C de mobictwolevelstudydata Mobi-C® CERVICAL DISC IDE Clinical Trial Overview Mobi-C Compared to Anterior Cervical Discectomy and Fusion at Two Contiguous Levels Mobi-C® demonstrated superiority in overall trial success compared to ACDF at two-levels key TriAL resuLTs Mobi-C demonstrated superiority in overall trial success compared to ACDF at 24 months.
November 6, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 6, 2013 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Numb
October 25, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 25, 2013 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Numb
October 25, 2013	EX-99.1	LDR ANNOUNCES PRESENTATION OF MOBI-C® CERVICAL DISC FOUR YEAR CLINICAL RESULTS AT THE NORTH AMERICAN SPINE SOCIETY ANNUAL MEETING Mobi-C is the first cervical disc replacement FDA approved for both one and two-level indications EXHIBIT 99.1 Media Contact: Gabrielle Zucker [email protected] (646) 747-7143 LDR ANNOUNCES PRESENTATION OF MOBI-C® CERVICAL DISC FOUR YEAR CLINICAL RESULTS AT THE NORTH AMERICAN SPINE SOCIETY ANNUAL MEETING Mobi-C is the first cervical disc replacement FDA approved for both one and two-level indications AUSTIN, TEXAS - October 25, 2013 - LDR Holding Corporation (NASDAQ: LDRH) (“LDR” or the “Comp
October 15, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 8, 2013 LDR HOLDING CORPORATION (Exact Name of Registrant as Specified in its Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 001-36095 (Commission File Numbe
October 10, 2013	EX-4.8	LDR HOLDING CORPORATION NOTICE OF GRANT OF STOCK OPTION EX-4.8 Exhibit 4.8 LDR HOLDING CORPORATION NOTICE OF GRANT OF STOCK OPTION Subject to the condition precedent set forth below, notice is hereby given of the following option grant (the “Option”) to purchase shares of the Common Stock of LDR Holding Corporation, a Delaware corporation (the “Corporation”): Optionee: Jean Blanchet Grant Date: November 17, 2006 Vesting Commencement Date: N/A Exercise
October 10, 2013	S-8	- S-8 S-8 As filed with the Securities and Exchange Commission on October 10, 2013 Registration No.
October 10, 2013	EX-4.7	LDR SPINE USA, INC. 2004 STOCK OPTION/STOCK ISSUANCE PLAN ARTICLE ONE GENERAL PROVISIONS EX-4.7 Exhibit 4.7 LDR SPINE USA, INC. 2004 STOCK OPTION/STOCK ISSUANCE PLAN ARTICLE ONE GENERAL PROVISIONS I. PURPOSE OF THE PLAN This Plan is intended to promote the interests of LDR Spine USA, Inc., a Delaware corporation (the “Corporation”), by providing eligible persons employed by or serving the Corporation with the opportunity to acquire a proprietary interest, or otherwise increase their p
October 9, 2013	FWP	LDR Holding Corporation FWP Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated October 8, 2013 Registration No.
October 9, 2013	424B1	The date of this prospectus is October 8, 2013. 424(b)(1) Table of Contents Filed Pursuant to Rule 424(b)(1) Registration No. 333-190829 5,000,000 Shares LDR HOLDING CORPORATION Common Stock $15.00 per share • LDR Holding Corporation is offering 5,000,000 shares. • The initial public offering price is $15.00 per share. • This is our initial public offering and no public market currently exists for our shares. • Our common stock has been approve
October 8, 2013	S-1/A	- AMENDMENT 3 TO FORM S-1 Amendment 3 to Form S-1 Table of Contents As filed with the Securities and Exchange Commission on October 8, 2013 Registration No.
October 8, 2013	EX-10.28	Between GREATBATCH MEDICAL SAS Z.I. La Vendue - BP 88 52000 Chaumont LDR MEDICAL 4, Rue Gustave Eiffel 10430 ROSIÈRES PRES TROYES EX-10.28 Exhibit 10.28 LDR Médical COMMERCIAL SUPPLIER AGREEMENT Document Ref.: CC FRN GB 01 Index: 10/15/2012 AM No.: Page 1 /12 [***] indicates material that has been omitted pursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission. A complete copy of this agreement, including redacted portions so indicated, has been filed separately with the Securities
October 8, 2013	CORRESP	- Letter to the SEC October 8, 2013 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.
October 8, 2013	EX-10.29	LDR HOLDING CORPORATION NON-EMPLOYEE INDEPENDENT DIRECTOR COMPENSATION POLICY EX-10.29 Exhibit 10.29 LDR HOLDING CORPORATION NON-EMPLOYEE INDEPENDENT DIRECTOR COMPENSATION POLICY This sets forth the Non-employee Independent Director Compensation Policy (the “Policy”) of LDR Holding Corporation (the “Company”), as adopted by the Compensation Committee of the Board of Directors of the Company (the “Board”), which shall remain in effect until amended, replaced or rescinded by
October 8, 2013	EX-10.9	LDR Holding Corporation AMENDED AND RESTATED 2013 EMPLOYEE STOCK PURCHASE PLAN The LDR Holding Corporation 2013 Employee Stock Purchase Plan EX-10.9 2 d547303dex109.htm EX-10.9 Exhibit 10.9 LDR Holding Corporation AMENDED AND RESTATED 2013 EMPLOYEE STOCK PURCHASE PLAN The LDR Holding Corporation 2013 Employee Stock Purchase Plan 1. ESTABLISHMENT, PURPOSE AND TERM OF PLAN. 1.1 Establishment. The LDR Holding Corporation 2013 Employee Stock Purchase Plan (the “Plan”) is hereby established effective as of the effective date of the initial
October 4, 2013	CORRESP	- Company Acceleration Request LDR Holding Corporation 13785 Research Boulevard, Suite 200 Austin, Texas 78750 October 4, 2013 VIA EDGAR Securities and Exchange Commission 100 F Street, N.
October 4, 2013	CORRESP	- Underwriters Acceleration Request October 4, 2013 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.
September 26, 2013	8-A12B	- FORM 8-A12B Form 8-A12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 LDR HOLDING CORPORATION (Exact name of registrant as specified in its charter) Delaware 20-3933262 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identi
September 19, 2013	EX-4.3.1	LDR HOLDING CORPORATION AMENDMENT NO. 2 TO INVESTORS’ RIGHTS AGREEMENT EX-4.3.1 Exhibit 4.3.1 LDR HOLDING CORPORATION AMENDMENT NO. 2 TO INVESTORS’ RIGHTS AGREEMENT THIS AMENDMENT NO. 2 TO INVESTORS’ RIGHTS AGREEMENT (this “Amendment”) is entered into as of September 12, 2013, by and among LDR Holding Corporation, a Delaware corporation (the “Company”) and certain Investors set forth on Exhibit A to that certain Amended and Restated Investors’ Rights Agreement dated
September 19, 2013	EX-10.4	LDR HOLDING CORPORATION NOTICE OF GRANT OF STOCK OPTION EX-10.4 Exhibit 10.4 LDR HOLDING CORPORATION NOTICE OF GRANT OF STOCK OPTION Notice is hereby given of the following option grant (the “Option”) to purchase shares of the Common Stock of LDR Holding Corporation (the “Corporation”): Optionee: Grant Date: Vesting Commencement Date: Exercise Price: per share Number of Option Shares: shares of Common Stock Expiration Date: Type of Option: Incentive St
September 19, 2013	S-1/A	- AMENDMENT 2 TO FORM S-1 Amendment 2 to Form S-1 Table of Contents As filed with the Securities and Exchange Commission on September 19, 2013 Registration No.
September 19, 2013	EX-4.4	SECOND AMENDED AND RESTATED PUT-CALL AGREEMENT By and Among LDR HOLDING CORPORATION, LDR Médical S.A.S., The Médical Shareholders and Warrant Holders Listed on Schedule A hereto The Médical Noteholders Listed on Schedule B hereto. Dated as of August EX-4.4 6 d547303dex44.htm EX-4.4 Exhibit 4.4 SECOND AMENDED AND RESTATED PUT-CALL AGREEMENT By and Among LDR HOLDING CORPORATION, LDR Médical S.A.S., and The Médical Shareholders and Warrant Holders Listed on Schedule A hereto and The Médical Noteholders Listed on Schedule B hereto. Dated as of August 6, 2013 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INTERPRETATION Section 1.01. Definitions
September 19, 2013	EX-10.5	LDR HOLDING CORPORATION 2013 EQUITY INCENTIVE PLAN LDR Holding Corporation 2013 Equity Incentive Plan EX-10.5 Exhibit 10.5 LDR HOLDING CORPORATION 2013 EQUITY INCENTIVE PLAN LDR Holding Corporation 2013 Equity Incentive Plan 1. ESTABLISHMENT, PURPOSE AND TERM OF PLAN. 1.1 Establishment. LDR Holding Corporation 2013 Equity Incentive Plan (the “Plan”) is hereby established effective the day prior to the effective date of the initial registration by the Company of its stock under Section 12 of the Se
September 19, 2013	EX-10.1	AMENDED AND RESTATED INDEMNIFICATION AGREEMENT EX-10.1 Exhibit 10.1 AMENDED AND RESTATED INDEMNIFICATION AGREEMENT THIS AMENDED AND RESTATED INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into this [ ] day of [ ], 2009, between LDR Holding Corporation, a Delaware corporation (the “Company”), and [NAME] (“Indemnitee”). INTRODUCTION: A. Indemnitee, as a member of the Company’s Board of Directors and/or an officer of the Company,
September 19, 2013	EX-10.29	LDR HOLDING CORPORATION NON-EMPLOYEE INDEPENDENT DIRECTOR COMPENSATION POLICY EX-10.29 Exhibit 10.29 LDR HOLDING CORPORATION NON-EMPLOYEE INDEPENDENT DIRECTOR COMPENSATION POLICY This sets forth the Non-employee Independent Director Compensation Policy (the “Policy”) of LDR Holding Corporation (the “Company”), as adopted by the Compensation Committee of the Board of Directors of the Company (the “Board”), which shall remain in effect until amended, replaced or rescinded by
September 19, 2013	EX-10.7	LDR HOLDING CORPORATION. NOTICE OF GRANT OF STOCK OPTION EX-10.7 Exhibit 10.7 LDR HOLDING CORPORATION. NOTICE OF GRANT OF STOCK OPTION The LDR Holding Corporation. (the “Company”) has granted to the Participant an option (the “Option”) to purchase certain shares of Stock of the Company pursuant to the LDR Holding Corporation Equity Incentive Plan (the “Plan”), as follows: Participant: Employee ID: Date of Grant: Number of Option Shares: , subject to adj
September 19, 2013	EX-3.2	AMENDED AND RESTATED BYLAWS LDR HOLDING CORPORATION, a Delaware corporation (initially adopted on [DATE]), to be effective upon the closing of the Corporation’s initial public offering Table of Contents Article I CORPORATE OFFICES 1 1.1 Registered Of EX-3.2 4 d547303dex32.htm EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF LDR HOLDING CORPORATION, a Delaware corporation (initially adopted on [DATE]), to be effective upon the closing of the Corporation’s initial public offering Table of Contents Article I CORPORATE OFFICES 1 1.1 Registered Office 1 1.2 Other Offices 1 Article II MEETINGS OF STOCKHOLDERS 1 2.1 Place of Meetings 1 2.2 Annual Me
September 19, 2013	EX-4.7.1	FIRST AMENDMENT TO WARRANT TO PURCHASE STOCK EX-4.7.1 Exhibit 4.7.1 FIRST AMENDMENT TO WARRANT TO PURCHASE STOCK This First Amendment to Warrant to Purchase Stock (this “Amendment”) is made as of the 12 day of September, 2013 by and between LDR HOLDING CORPORATION, a Delaware corporation (the “Company”), and Comerica Ventures Incorporated, a California Corporation, the holder of the Warrant (as hereinafter defined) (the “Holder”). A. The Hol
September 19, 2013	EX-3.1	LDR HOLDING CORPORATION AMENDED AND RESTATED CERTIFICATE OF INCORPORATION EX-3.1 Exhibit 3.1 LDR HOLDING CORPORATION AMENDED AND RESTATED CERTIFICATE OF INCORPORATION LDR Holding Corporation (the “Corporation”), a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify: FIRST: That the Corporation was originally incorporated pursuant to the DGCL on December 13, 200
September 19, 2013	EX-1.1	[ • ] Shares LDR Holding Corporation Common Stock PURCHASE AGREEMENT EX-1.1 2 d547303dex11.htm EX-1.1 Exhibit 1.1 [ • ] Shares LDR Holding Corporation Common Stock PURCHASE AGREEMENT [ • ], 2013 PIPER JAFFRAY & CO. As Representative of the several Underwriters named in Schedule I hereto c/o Piper Jaffray & Co. 800 Nicollet Mall Minneapolis, Minnesota 55402 Ladies and Gentlemen: LDR Holding Corporation, a Delaware corporation (the “Company”), proposes to sell to the
September 19, 2013	EX-10.9	LDR Holding Corporation 2013 EMPLOYEE STOCK PURCHASE PLAN The LDR Holding Corporation 2013 Employee Stock Purchase Plan EX-10.9 Exhibit 10.9 LDR Holding Corporation 2013 EMPLOYEE STOCK PURCHASE PLAN The LDR Holding Corporation 2013 Employee Stock Purchase Plan 1. ESTABLISHMENT, PURPOSE AND TERM OF PLAN. 1.1 Establishment. The LDR Holding Corporation 2013 Employee Stock Purchase Plan (the “Plan”) is hereby established effective as of the effective date of the initial registration by the Company of its Stock under Se
September 19, 2013	EX-10.13	LDR SPINE USA, INC. EMPLOYMENT, CONFIDENTIAL INFORMATION, INVENTION ASSIGNMENT, NON-COMPETE, AND NON- SOLICITATION AGREEMENT EX-10.13 17 d547303dex1013.htm EX-10.13 Exhibit 10.13 LDR SPINE USA, INC. EMPLOYMENT, CONFIDENTIAL INFORMATION, INVENTION ASSIGNMENT, NON-COMPETE, AND NON- SOLICITATION AGREEMENT As a condition of my employment with LDR Spine USA, Inc., its subsidiaries, affiliates, successors or assigns (together the “Company”), and in consideration of my further employment with the Company and my receipt of the
September 19, 2013	CORRESP	- CORRESP 111 Congress Avenue, Suite 1700 Austin, Texas 78701 512.320.9200 Phone 512.320.9292 Fax andrewskurth.com September 19, 2013 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington D.C. 20549-4561 Mail Stop 4561 RE: LDR Holding Corporation Registration Statement on Form S-1 Amendment No. 1 filed on August 29, 2013 File No. 333-190829 Ladies
September 19, 2013	EX-10.8	LDR HOLDING CORPORATION STOCK OPTION AGREEMENT EX-10.8 15 d547303dex108.htm EX-10.8 Exhibit 10.8 FOR USE IN BRAZIL, FRANCE AND GERMANY LDR HOLDING CORPORATION STOCK OPTION AGREEMENT The LDR Holding Corporation (the “Company”) has granted to the Participant named in the Notice of Grant of Stock Option (the “Grant Notice”) to which this Stock Option Agreement (the “Option Agreement”) is attached an option (the “Option”) to purchase certain share
September 19, 2013	EX-4.11	AMENDED AND RESTATED VOTING AGREEMENT EX-4.11 Exhibit 4.11 AMENDED AND RESTATED VOTING AGREEMENT THIS AMENDED AND RESTATED VOTING AGREEMENT (this “Agreement”) is made as of September 12, 2013, by and among LDR Holding Corporation, a Delaware corporation (the “Company”) and the stockholders set forth on Annex A and Annex B hereto (collectively, the “Stockholders”). WHEREAS, in connection with the Company’s proposed initial public offer
September 19, 2013	EX-10.6	LDR HOLDING CORPORATION STOCK OPTION AGREEMENT EX-10.6 Exhibit 10.6 LDR HOLDING CORPORATION STOCK OPTION AGREEMENT The LDR Holding Corporation (the “Company”) has granted to the Participant named in the Notice of Grant of Stock Option (the “Grant Notice”) to which this Stock Option Agreement (the “Option Agreement”) is attached an option (the “Option”) to purchase certain shares of Stock upon the terms and conditions set forth in the Grant Not
September 17, 2013	CORRESP	- 111 Congress Avenue, Suite 1700 Austin, Texas 78701 512.320.9200 Phone 512.320.9292 Fax andrewskurth.com September 17, 2013 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-4561 Mail Stop 4561 RE: LDR Holding Corporation Registration Statement on Form S-1 Amendment No. 1 filed on August 29, 2013 File No. 333-190829 Ladies and Ge
August 29, 2013	EX-10.1	AMENDED AND RESTATED INDEMNIFICATION AGREEMENT EX-10.1 Exhibit 10.1 AMENDED AND RESTATED INDEMNIFICATION AGREEMENT THIS AMENDED AND RESTATED INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into this [ ] day of [ ], 2009, between LDR Holding Corporation, a Delaware corporation (the “Company”), and [NAME] (“Indemnitee”). INTRODUCTION: A. Indemnitee, as a member of the Company’s Board of Directors and/or an officer of the Company,
August 29, 2013	S-1/A	- AMENDMENT NUMBER 1 TO FORM S-1 Amendment Number 1 to Form S-1 Table of Contents As filed with the Securities and Exchange Commission on August 28, 2013 Registration No.
August 29, 2013	EX-10.13	LDR SPINE USA, INC. EMPLOYMENT, CONFIDENTIAL INFORMATION, INVENTION ASSIGNMENT, NON-COMPETE, AND NON- SOLICITATION AGREEMENT EX-10.13 Exhibit 10.13 LDR SPINE USA, INC. EMPLOYMENT, CONFIDENTIAL INFORMATION, INVENTION ASSIGNMENT, NON-COMPETE, AND NON- SOLICITATION AGREEMENT As a condition of my employment with LDR Spine USA, Inc., its subsidiaries, affiliates, successors or assigns (together the “Company”), and in consideration of my further employment with the Company and my receipt of the compensation now and hereafter
August 28, 2013	CORRESP	- Response Letter 111 Congress Avenue, Suite 1700 Austin, Texas 78701 512.320.9200 Phone 512.320.9292 Fax andrewskurth.com August 28, 2013 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington D.C. 20549-4561 Mail Stop 4561 RE: LDR Holding Corporation Confidential Draft Registration Statement on Form S-1 Submitted on July 18, 2013 CIK No. 00013483
August 27, 2013	CORRESP	- CORRESP 111 Congress Avenue, Suite 1700 Austin, Texas 78701 512.320.9200 Phone 512.320.9292 Fax andrewskurth.com August 27, 2013 001 FOIA CONFIDENTIAL TREATMENT REQUESTED BY LDR HOLDING CORPORATION Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington D.C. 20549-4561 Mail Stop 4561 RE: LDR Holding Corporation Confidential Draft Registration Statement on F
August 26, 2013	EX-10.27	Invibio™ biomaterial solutions INVIBIO LIMITED LDR MEDICAL LIMITED TERRITORY AGREEMENT FOR THE SUPPLY OF STOCK SHAPE Confidential Page 1 of 27 Clause Page 1. INTERPRETATION 4 2. SUPPLY OF THE STOCK SHAPE 5 3. TERM 5 4. ORDERS 5 5. DELIVERY 6 6. RISK EX-10.27 Exhibit 10.27 [***] indicates material that has been omitted pursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission. A complete copy of this agreement, including redacted portions so indicated, has been filed separately with the Securities Exchange Commission. Invibio™ biomaterial solutions INVIBIO LIMITED AND LDR MEDICAL LIMITED TERRITORY AGREE
August 26, 2013	EX-10.23	AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT dated as of February 11, 2011 by and among ESCALATE CAPITAL I, L.P., as Lender, LDR SPINE USA, INC., LDR HOLDING CORP©RATION, as Borrowers TABLE OF CONTENTS Page 1. THE LOAN 1 1.1 Commitment 1 1.2 Inte EX-10.23 Exhibit 10.23 EXECUTION COPY AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT dated as of February 11, 2011 by and among ESCALATE CAPITAL I, L.P., as Lender, LDR SPINE USA, INC., and LDR HOLDING CORP©RATION, as Borrowers TABLE OF CONTENTS Page 1. THE LOAN 1 1.1 Commitment 1 1.2 Interest, Payments, Payment Terms, and Facility Fee 1 1.3 Facility Fee 3 1.4 Lender Expenses 3 1.5 Joint and Sev
August 26, 2013	EX-10.22	FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT EX-10.22 Exhibit 10.22 FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT This Fifth Amendment to Loan and Security Agreement (this “Amendment”) is entered into as of April 25, 2012, by and between COMERICA BANK (“Bank”) and LDR HOLDING CORPORATION and LDR SPINE USA, INC. (each a “Borrower” and collectively, “Borrowers”). RECITALS Borrowers and Bank are parties to that certain Loan and Security Agreem
August 26, 2013	EX-10.19	SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT EX-10.19 Exhibit 10.19 SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT This Second Amendment to Loan and Security Agreement (this “Amendment”) is entered into on December 9, 2010, and is effective as of September 30, 2010, by and between COMERICA BANK (“Bank”) and LDR HOLDING CORPORATION (“Parent”) and LDR SPINE USA, INC. (each a “Borrower” and collectively, “Borrowers”). RECITALS Borrowers and Ba
August 26, 2013	EX-4.3	LDR HOLDING CORPORATION AMENDMENT NO. 1 TO INVESTORS’ RIGHTS AGREEMENT EX-4.3 3 d547303dex43.htm EX-4.3 Exhibit 4.3 LDR HOLDING CORPORATION AMENDMENT NO. 1 TO INVESTORS’ RIGHTS AGREEMENT THIS AMENDMENT NO. 1 TO INVESTORS’ RIGHTS AGREEMENT (this “Amendment”) is entered into as of April 25, 2012, by and among LDR Holding Corporation, a Delaware corporation (the “Company”) and certain Investors set forth on Exhibit A to that certain Amended and Restated Investors’ Right
August 26, 2013	EX-10.10	June 10, 2013 EX-10.10 Exhibit 10.10 June 10, 2013 Christophe Lavigne Re: EMPLOYMENT TERMS Dear Christophe: LDR Holding Corporation (the “Company”) is pleased to offer to continue your employment as President and Chief Executive Officer of the Company on the terms and conditions set forth in this letter, effective as of June 10, 2013 (the “Effective Date”). This letter amends and restates in its entirety any pr
August 26, 2013	EX-10.28	Between GREATBATCH MEDICAL SAS Z.I. La Vendue - BP 88 52000 Chaumont LDR MEDICAL 4, Rue Gustave Eiffel 10430 ROSIÈRES PRES TROYES EX-10.28 28 d547303dex1028.htm EX-10.28 Exhibit 10.28 LDR Médical COMMERCIAL SUPPLIER AGREEMENT Document Ref.: CC FRN GB 01 Index: 10/15/2012 AM No.: Page 1 /12 [***] indicates material that has been omitted pursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission. A complete copy of this agreement, including redacted portions so indicated, has been filed
August 26, 2013	EX-4.5	AMENDED AND RESTATED VOTING AGREEMENT EX-4.5 Exhibit 4.5 AMENDED AND RESTATED VOTING AGREEMENT THIS AMENDED AND RESTATED VOTING AGREEMENT dated as of September 11, 2007 (this “Agreement”) is entered into by and among (i) LDR Holding Corporation, a Delaware corporation (the “Company”), (ii) the persons listed as Investors on Schedule A hereto (each, an “Investor” and collectively, the “Investors”), (iii) the persons listed on Schedule
August 26, 2013	S-1	Registration Statement - FORM S-1 Form S-1 Table of Contents As filed with the Securities and Exchange Commission on August 26, 2013 Registration No.
August 26, 2013	EX-4.6	AMENDED AND RESTATED FIRST REFUSAL AND CO-SALE AGREEMENT EX-4.6 Exhibit 4.6 AMENDED AND RESTATED FIRST REFUSAL AND CO-SALE AGREEMENT THIS AMENDED AND RESTATED FIRST REFUSAL AND CO-SALE AGREEMENT (this “Agreement”), is made as of September 11, 2007, by and among LDR Holding Corporation, a Delaware corporation (the “Company”), each of the individuals and entities listed on Schedule A attached hereto (the “Investors”), and each of the individuals listed on

LDRH / iShares Trust - iShares iBonds 1-5 Year High Yield and Income Ladder ETF - SEC-arkiveringar, Årsredovisning, Fullmaktsutlåtande

Grundläggande statistik

SEC Filings

SEC Filings (Chronological Order)